Literature DB >> 33573555

Regenerative Potential of Mesenchymal Stem Cell-Derived Extracellular Vesicles.

Dineshi Sewvandi Thalakiriyawa1, Primali Rukmal Jayasooriya1, Waruna Lakmal Dissanayaka2.   

Abstract

Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into diverse cell lineages. MSC based therapy has become a widely experimented treatment strategy in regenerative medicine with promising outcomes. Recent reports suggest that much of the therapeutic effects of MSCs are mediated by their secretome that is expressed through extracellular vesicles (EVs). EVs are lipid bilayer bound components that carry cellular proteins, mRNA, lncRNAs, and other molecules in order to mediate intercellular communication and signaling. In fact, MSC-derived EVs have been observed to implement the same therapeutic effects as MSCs with minimal adverse effects and could be used as an alternative treatment method to MSC-based therapy. The regenerative activity of MSC-EVs has been observed in relation to multiple cell/tissue lineages using various animal models. However, further research and clinical trials are essential for the advancement of this novel treatment strategy. This review provides an insight into the available literature on applications of MSC-EVs in relation to angiogenesis, neurogenesis, hepatic and kidney regeneration, and wound healing. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Extracellular vesicles; mesenchymal stem cells; paracrine signaling; regeneration.; regenerative medicine; secretome

Mesh:

Year:  2022        PMID: 33573555     DOI: 10.2174/1566524021666210211114453

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  2 in total

Review 1.  Potential Therapeutic Effect and Mechanisms of Mesenchymal Stem Cells-Extracellular Vesicles in Renal Fibrosis.

Authors:  Chunling Liao; Guangyong Chen; Qian Yang; Yiping Liu; Tianbiao Zhou
Journal:  Front Cell Dev Biol       Date:  2022-03-11

2.  Melatonin Protects Chronic Kidney Disease Mesenchymal Stem/Stromal Cells against Accumulation of Methylglyoxal via Modulation of Hexokinase-2 Expression.

Authors:  Gyeongyun Go; Yeo Min Yoon; Sungtae Yoon; Gaeun Lee; Ji Ho Lim; Su-Yeon Han; Sang Hun Lee
Journal:  Biomol Ther (Seoul)       Date:  2022-01-01       Impact factor: 4.634

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.